SummitTX Capital L.P. Sells 13,466 Shares of Agilent Technologies, Inc. $A

SummitTX Capital L.P. decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 58.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,525 shares of the medical research company’s stock after selling 13,466 shares during the quarter. SummitTX Capital L.P.’s holdings in Agilent Technologies were worth $1,086,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of A. Massachusetts Financial Services Co. MA raised its stake in Agilent Technologies by 13.8% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after purchasing an additional 1,713,216 shares in the last quarter. State Street Corp increased its holdings in shares of Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after buying an additional 241,029 shares during the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares in the last quarter. Morgan Stanley lifted its holdings in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock worth $686,049,000 after acquiring an additional 692,202 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Agilent Technologies during the 4th quarter worth $549,158,000.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Weiss Ratings raised Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Wells Fargo & Company cut their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, May 28th. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and reduced their price objective for the company from $150.00 to $145.00 in a research report on Thursday, May 28th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 target price for the company. Finally, TD Cowen upped their target price on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Stock Performance

NYSE A opened at $140.31 on Thursday. The company has a 50-day simple moving average of $131.41 and a two-hundred day simple moving average of $125.27. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.27. The firm has a market cap of $39.63 billion, a price-to-earnings ratio of 28.17, a PEG ratio of 2.49 and a beta of 1.25. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts forecast that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.